Table 5. Favorable and unfavorable changes in the expression of significantly differential expressed proteins after metformin treatment.
significantly differential expressed proteins after metformin administration | ||
---|---|---|
favorable regulation: | AKT3, CCND2, CD63, CD81, GFAP, IL5, IL17A, IRF4, PI3, VTCN1 | (IL1B, IL2) |
unfavorable regulation: | CTSL, GUSB, TFRC |